大象传媒 Endocrinology, Diabetes, and Obesity Clinical Research Unit
Our Team
-
Director
Medical Director
Program Manager
Lead Investigator for Obesity and Lipid Trials
Finance Manager
Lead Clinical Research Coordinator
-
Director
Medical Director
Lead Investigator for Obesity and Lipid Trials
-
Program Manager
Lead Clinical Research Coordinator
Why do research sponsors conduct research at EnDO CRU & why do patients want to participate?
- Renowned Expertise:聽Our team includes leading endocrinologists, clinical researchers, and operational experts聽who lead studies with potential to make a difference in people鈥檚 lives. We collaborate with both academic and industry partners to push the boundaries of discovery.
- Efficient & Reliable Execution, with care:聽Our teams operates within a highly structured, regulatory-compliant聽research framework, ensuring that trials are conducted with precision, integrity, and speed. Most importantly, we care deeply about our participants.
- Representative Patient Population: We aim to enroll participants from across the state reflecting the demographics of North Carolina’s population. NC’s people are among the most varied by background in the US with聽the second largest rural population and the largest Native American population east of the Mississippi.
- State-of-the-Art Facilities:聽Our dedicated research unit at 大象传媒鈥檚 Eastowne Clinical Research Facility聽offers cutting-edge infrastructure, including specialized labs, on-site phlebotomy, investigational聽drug services support, and a dedicated clinical trials team.
- Seamless Study Integration:聽We work with healthcare providers to integrate research into routine clinical care, enhancing participant engagement and care.
Recent Publications
Collaboration Opportunities
Partnering with EnDO CRU聽means working with a team committed to scientific excellence, innovation, and patient-centered research. Whether you’re looking to test a promising new therapy, explore novel mechanisms of action, or evaluate real-world treatment outcomes, we have the expertise and infrastructure聽for your study to succeed.We invite pharmaceutical companies, biotech firms, and medical device manufacturers聽to partner with us in conducting:
- Early-phase clinical trials (First-in-Human, Phase I)
- Late-stage clinical research (Phase II鈥揑V)
- Post-market studies and real-world evidence generation
- Investigator-initiated trials and collaborative projects
Contact
Contact the email or number below to discuss how we can collaborate to drive the next breakthrough in endocrine and metabolic health.
- uncdiabetes@med.unc.edu
- 984-974-3004
